Future of Personalized Therapy Targeting Aberrant Signaling Pathways in Multiple Myeloma
Faiz Anwer(Cleveland Clinic), Christy Samaras(Cleveland Clinic), Jennifer S. Carew(University of Arizona), Hussam Al‐Kateb(Washington University in St. Louis), Ali McBride(University of Arizona), Steffan T. Nawrocki(University of Arizona), Mirza Muhammad Faran Ashraf Baig(Chinese University of Hong Kong), Faryal Razzaq(University of Arizona), Jason Valent(Cleveland Clinic), Sabina Saeed(University of Arizona), Kevin Gee(University of Arizona), Atlantis Dawn Russ(University of Arizona), Ahmad Iftikhar(University of Arizona), Muhammad Abu Zar(University of Arizona), Nadia Nunes Cavalcante Parr(University of Arizona)
Cited by 23
Related Papers
Survivin: Key Regulator of Mitosis and Apoptosis and Novel Target for Cancer Therapeutics
|Clinical Cancer Research|2008|782
Chitosan oligosaccharide (COS): An overview
|International Journal of Biological Macromolecules|2019|490